Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Nuwellis (CHFS) Competitors

Nuwellis logo

CHFS vs. CUTR, VRAYQ, VIVE, ELMD, QTI, NRXS, ENSC, ARTL, APM, and MYNZ

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Cutera (CUTR), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), QT Imaging (QTI), NeurAxis (NRXS), Ensysce Biosciences (ENSC), Artelo Biosciences (ARTL), Aptorum Group (APM), and Mainz Biomed (MYNZ).

Nuwellis vs. Its Competitors

Nuwellis (NASDAQ:CHFS) and Cutera (NASDAQ:CUTR) are both small-cap electromedical equipment industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

In the previous week, Nuwellis' average media sentiment score of 0.00 equaled Cutera'saverage media sentiment score.

Company Overall Sentiment
Nuwellis Neutral
Cutera Neutral

Nuwellis has higher earnings, but lower revenue than Cutera. Nuwellis is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$5.51M8.66-$18.11M-$279.28-0.03
Cutera$155.21M0.01-$162.83M-$6.58-0.01

Cutera has a net margin of -84.86% compared to Nuwellis' net margin of -254.26%. Cutera's return on equity of 0.00% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-254.26% -173.61% -131.01%
Cutera -84.86%N/A -45.07%

Cutera has a consensus price target of $3.00, suggesting a potential upside of 7,592.31%. Given Cutera's stronger consensus rating and higher possible upside, analysts plainly believe Cutera is more favorable than Nuwellis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuwellis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cutera
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Nuwellis has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Cutera has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500.

65.1% of Nuwellis shares are held by institutional investors. Comparatively, 90.7% of Cutera shares are held by institutional investors. 0.6% of Nuwellis shares are held by insiders. Comparatively, 0.4% of Cutera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Cutera beats Nuwellis on 10 of the 14 factors compared between the two stocks.

Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHFS vs. The Competition

MetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$47.69M$34.52M$5.55B$9.01B
Dividend YieldN/AN/A5.25%4.03%
P/E Ratio-0.163.4728.0720.17
Price / Sales8.66195.25432.62124.64
Price / CashN/A41.3636.8257.86
Price / Book0.622.198.125.62
Net Income-$18.11M-$25.54M$3.16B$248.50M

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHFS
Nuwellis
N/A$7.90
+11.1%
N/A+76.9%$47.69M$5.51M-0.1666
CUTR
Cutera
N/A$0.04
-63.9%
$3.00
+7,592.3%
-97.2%$787K$155.21M-0.01460Gap Down
High Trading Volume
VRAYQ
ViewRay
N/A$0.00
+∞
N/AN/A$18K$102.21M0.00300High Trading Volume
VIVE
Viveve Medical
N/A$0.00
flat
N/AN/A$1K$6.83M0.0070High Trading Volume
ELMD
Electromed
1.5027 of 5 stars
$21.80
-0.9%
$38.00
+74.3%
+34.9%$182.82M$61.44M29.07160
QTI
QT Imaging
N/A$1.33
-4.1%
N/A+157.9%$36.16M$4.00M0.00N/ANews Coverage
Gap Up
NRXS
NeurAxis
3.4881 of 5 stars
$2.38
-1.7%
$7.00
+194.1%
-9.2%$17.17M$2.93M-1.2919
ENSC
Ensysce Biosciences
0.0827 of 5 stars
$2.24
+0.4%
N/A-68.5%$5.31M$5.21M-0.3410
ARTL
Artelo Biosciences
2.2907 of 5 stars
$9.50
-28.4%
$33.00
+247.4%
+100.7%$5.23MN/A-0.535News Coverage
Analyst Upgrade
Gap Up
High Trading Volume
APM
Aptorum Group
0.511 of 5 stars
$0.94
+2.7%
N/A-77.2%$5.00M$430K0.0030Gap Up
MYNZ
Mainz Biomed
3.0769 of 5 stars
$1.42
+0.7%
$14.00
+885.9%
-92.4%$4.89M$890K-0.0230Gap Up

Related Companies and Tools


This page (NASDAQ:CHFS) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners